Recall
FDAHealthAugust 22, 2024

ProRx LLC — TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02

⚠️ Lack of Assurance of Sterility

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
August 22, 2024

Nationwide in the USA

What's affected?

Product
TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02
Lot code
ProRx052224

Additional details

Lot# ProRx052224, BUD 11/21/2024 ProRx061024, BUD 12/09/2024

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 1,732 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.